The Phase I/II clinical trial of the novel Cell Pouch System recruited 18-to-65-year-old type 1 diabetics who’d had the condition for more than five years and had a history of severe ...
Ltd. (Osaka, Japan, “Ono”) has selected multiple targets identified using Turbine’s in silico Simulated Cell™ platform for further development. Turbine will now lead in vitro validation of the ...
Cell C has confirmed that it did not secure the radio frequency spectrum it won in the 2022 auction. Cell C CEO Jorge Mendes told MyBroadband this was because a payment arrangement the operator ...